Real-world efficacy and safety of combined first-line treatment with PARP inhibitors and novel hormonal therapy in mCRPC patients with HRR gene mutations - Guo, Andong; Wu, Chenrui; Cao, Jishuang; Zhu, Kejia; Ding, Sentai (Frontiers in Genetics, 2024)